Annual revenue moved from KRW 542 million in 2022 to KRW 2.73 billion in 2023, KRW 1.6 billion in 2024 and KRW 5.12 billion in 2025. Revenue rose 404.5% in 2023 and fell 41.4% in 2024 before rising 219.8% in 2025, making 2025 the largest year in the 2022 to 2025 span.
The operating loss was KRW 15.6 billion in 2022, KRW 16.1 billion in 2023, KRW 22.8 billion in 2024 and KRW 20.1 billion in 2025. The loss widened year on year in 2023 and 2024 and narrowed in 2025.
Operating margin was -2,884.8% in 2022, -590.3% in 2023, -1,423.4% in 2024 and -392.0% in 2025, so loss ratios were extreme in years when sales were small. The 2025 ratio improved from 2024 mainly because sales growth outpaced the reduction in the loss.
The loss attributable to controlling shareholders was KRW 13.7 billion in 2022, KRW 16.3 billion in 2023, KRW 22.5 billion in 2024 and KRW 20 billion in 2025, and the net loss including non-controlling interests was reported at the same amounts.
At the end of 2025, total equity was KRW 25.7 billion, of which KRW 25.7 billion was attributable to controlling shareholders, and total liabilities were KRW 13.5 billion. The debt ratio was reported at 126.9% in 2022, 29.3% in 2023, 87.5% in 2024 and 52.7% in 2025.
Operating cash flow was -KRW 14.5 billion in 2022, -KRW 15.3 billion in 2023, -KRW 20.1 billion in 2024 and -KRW 20.5 billion in 2025, so the cash outflow grew every year.
Quarterly revenue rose from KRW 1.08 billion in Q3 2025 to KRW 1.24 billion in Q4 2025 (up 15.0% quarter on quarter), then fell to KRW 322 million in Q1 2026 (down 74.1%).
Revenue recovered to KRW 1.01 billion in Q2 2026 (up 213.2%) and was KRW 512 million in Q3 2026 (down 49.3% quarter on quarter and down 52.7% year on year).
Quarterly operating losses were KRW 3.94 billion in Q3 2025, KRW 6.69 billion in Q4 2025, KRW 4.85 billion in Q1 2026, KRW 4.8 billion in Q2 2026 and KRW 4.52 billion in Q3 2026. The loss attributable to controlling shareholders for the last four quarters totaled KRW 20.8 billion.
The company said it shipped 78 devices to customers in Q1 2026, made up of 7 actual sales and 71 purchase-conditional placements, and that some revenue shifted into Q2. The company's IR material put gross margin at 60.7% in Q3 2025, and the company attributes the losses to regulatory approvals and R&D spending.